Atomi Financial Group Inc. Has $865,000 Stake in CME Group Inc. (NASDAQ:CME)

Atomi Financial Group Inc. boosted its position in CME Group Inc. (NASDAQ:CME) by 34.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,725 shares of the financial services provider’s stock after purchasing an additional 947 shares during the period. Atomi Financial Group Inc.’s holdings in CME Group were worth $865,000 at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. Truvestments Capital LLC bought a new position in CME Group in the 3rd quarter valued at approximately $26,000. Dunhill Financial LLC lifted its holdings in shares of CME Group by 188.4% during the third quarter. Dunhill Financial LLC now owns 124 shares of the financial services provider’s stock worth $27,000 after purchasing an additional 81 shares during the period. Fortitude Family Office LLC grew its stake in shares of CME Group by 120.3% in the fourth quarter. Fortitude Family Office LLC now owns 152 shares of the financial services provider’s stock worth $35,000 after purchasing an additional 83 shares during the last quarter. Thurston Springer Miller Herd & Titak Inc. increased its holdings in CME Group by 62.2% in the third quarter. Thurston Springer Miller Herd & Titak Inc. now owns 193 shares of the financial services provider’s stock valued at $43,000 after purchasing an additional 74 shares during the period. Finally, Anchor Investment Management LLC lifted its holdings in CME Group by 52.4% during the 3rd quarter. Anchor Investment Management LLC now owns 378 shares of the financial services provider’s stock worth $83,000 after buying an additional 130 shares during the period. 87.75% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several equities research analysts have recently weighed in on the company. Deutsche Bank Aktiengesellschaft decreased their price target on CME Group from $227.00 to $226.00 and set a “hold” rating for the company in a research note on Monday, November 11th. Keefe, Bruyette & Woods dropped their price target on shares of CME Group from $260.00 to $256.00 and set a “market perform” rating on the stock in a research report on Monday, January 13th. TD Cowen assumed coverage on shares of CME Group in a research report on Thursday, September 26th. They set a “hold” rating and a $221.00 price objective for the company. Royal Bank of Canada restated a “sector perform” rating and issued a $235.00 target price on shares of CME Group in a report on Monday, January 6th. Finally, Oppenheimer increased their price target on CME Group from $245.00 to $258.00 and gave the stock an “outperform” rating in a report on Thursday, October 24th. Four analysts have rated the stock with a sell rating, eight have given a hold rating and three have given a buy rating to the company. According to MarketBeat, CME Group presently has an average rating of “Hold” and an average price target of $229.27.

Insider Transactions at CME Group

In related news, Director Martin J. Gepsman sold 400 shares of the firm’s stock in a transaction dated Monday, November 4th. The shares were sold at an average price of $222.92, for a total transaction of $89,168.00. Following the transaction, the director now directly owns 25,067 shares of the company’s stock, valued at $5,587,935.64. This trade represents a 1.57 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Timothy Francis Mccourt sold 1,374 shares of the company’s stock in a transaction dated Monday, October 28th. The stock was sold at an average price of $227.12, for a total transaction of $312,062.88. Following the completion of the sale, the insider now directly owns 7,275 shares of the company’s stock, valued at $1,652,298. The trade was a 15.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 7,274 shares of company stock valued at $1,648,071 over the last ninety days. 0.30% of the stock is currently owned by insiders.

CME Group Price Performance

Shares of CME opened at $232.53 on Thursday. The stock has a market cap of $83.79 billion, a P/E ratio of 24.45, a P/E/G ratio of 5.28 and a beta of 0.56. The business’s fifty day moving average is $233.55 and its 200 day moving average is $220.60. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.09. CME Group Inc. has a 12-month low of $190.70 and a 12-month high of $249.02.

CME Group (NASDAQ:CME) last posted its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 EPS for the quarter, topping the consensus estimate of $2.65 by $0.03. CME Group had a net margin of 57.34% and a return on equity of 13.39%. The company had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.59 billion. During the same period in the previous year, the firm posted $2.25 earnings per share. The firm’s revenue for the quarter was up 18.4% on a year-over-year basis. Sell-side analysts anticipate that CME Group Inc. will post 10.18 earnings per share for the current fiscal year.

CME Group Increases Dividend

The business also recently disclosed a dividend, which was paid on Thursday, January 16th. Shareholders of record on Friday, December 27th were issued a dividend of $5.80 per share. This is a positive change from CME Group’s previous dividend of $2.50. The ex-dividend date was Friday, December 27th. CME Group’s payout ratio is currently 48.37%.

CME Group declared that its Board of Directors has initiated a share repurchase plan on Thursday, December 5th that allows the company to repurchase $3.00 billion in shares. This repurchase authorization allows the financial services provider to buy up to 3.4% of its stock through open market purchases. Stock repurchase plans are generally a sign that the company’s board of directors believes its shares are undervalued.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.